icone plus
Contact Abonnez-vous aux actualités
Reason for request
Inclusion
Clinical Benefit
Substantial
Substantial actual benefit
Clinical Added Value
no clinical added value
EYLEA 40 mg/ml, solution for injection in a prefilled syringe and solution for injection in a vial, does not provide an improvement in actual benefit (IAB V) compared with LUCENTIS 10 mg/ml, solution for injection.
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
g3BXVUc4hP6e8nBZ
Listen
